IND application submitted for first-in-human study of AFM24, a bispecific EGFR/CD16A innate cell engager for solid tumors FDA clearance of IND for first clinical study of a stable complex of AFM13 pre-mixed with cord blood-derived allogeneic NK cells in patients with relapsed...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 120 weeks of public selections as part of this ongoing live forward-testing. In...

The following slide deck was published by Affimed N.V. in conjunction with this Read more ...